RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF CLINDAMYCIN PHOSPHATE AND CLOTRIMAZOLE IN PHARMACEUTICAL DOSAGE FORMS
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 1
Abstract
Objective: The aim of this work was to develop and validate a simple Reverse Phase-High Performance Liquid Chromatography method for the simultaneous estimation of Clindamycin and Clotrimazole in pharmaceutical dosage forms.Methods: The mobile phase consists of phosphate buffer and Acetonitrile in the ratio of (48:52) with gradient programming, Hypersil BDS (250×4.6 mm,5µ) column used as stationary phase with a flow rate of 1 ml/min, injection volume 10 µl and the run time was 10 min. Detection wavelength was at 220 nm by using Photo Diode Array detector.Results: The retention times of Clindamycin and Clotrimazole were found to be 2.2 min and 5.7 min respectively. The method was validated according to ICH guidelines. Validation parameters like accuracy, precision, linearity, range, limit of detection, limit of quantification and robustness all were within the limits. The linearity responses of Clindamycin and Clotrimazole were found to be in the concentration ranges of 25-150 µg/ml and 50-300 µg/ml. The percentage recovery for both drugs was found in the range of 99-100%. The LOD & LOQ values for were found to be 1.29µg/ml and 3.93µg/ml and Clotrimazole were found to be 1.31µg/ml and 3.96 µg/ml, respectively.Conclusion: The results obtained are accurate and within the limits. Hence this method can be applicable for the estimation of Clindamycin and Clotrimazole in pharmaceutical dosage forms.Â
Authors and Affiliations
M. Sudhakar, K. Vijayasri, Sridhar Siddiraju, Maturi Nirupama
Keywords
Related Articles
- EP ID EP579197
- DOI -
- Views 73
- Downloads 0
RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS QUANTITATIVE ESTIMATION OF METRONIDAZOLE AND NALIDIXIC ACID IN TABLETS
Objective: To develop an accurate, precise and linear Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method for simultaneous quantitative estimation of Metronidazole and Nalidixic acid in tablets and val...
CONTROLLED RELEASE IBUPROFEN NANOPARTICLES: PHYSICO-CHEMICAL CHARACTERIZATION AND DRUG RELEASE
Objectives: The effect of lipid phase composition, concentration of lipid and surfactant on the entrapment, morphology, particle size and release profiles of ibuprofen-loaded lipid particles was evaluated.Methods: Formul...
COMPARATIVE ANALYSIS OF POTENTIALITY OF ESCULIN AND HINOKITOL (Î’-THUJAPLICIN) AS ANTI-PARKINSONISM DRUGS: A PILOT IN SILICO STUDY
Objective: Parkinson’s disease (PD) is a leading cause of mental disability and death worldwide. Even though there are many advances in drug development against PD, a potent low dosage drug with fewer side effects are...
SURVIVAL ANALYSIS FOR THE RISK OF DEVELOPING HEART ATTACK
Heart disease is the leading cause of death among Filipinos, accounting for 1 out of every 5 deaths in the past year. Each year, 170,000 Filipinos die from cardiovascular diseases, up from 85,000 more than 20 y ago. This...
COMPARATIVE LC-MS STABILITY INDICATIND ASSAYS OF ONDANSETRON HYDROCHLORIDE/NALOXONE HYDROCHLORIDE AND METOCLOPRAMIDE HYDROCHLORIDE/NALOXONE HYDROCHLORIDE USED IN PALLIATIVE CARE
Objectives: To compare the compatibility and chemical stability of ondansetron hydrochloride/naloxone hydrochloride and metoclopramide hydrochloride/naloxone hydrochloride admixtures used in palliative care units at thre...